Literature DB >> 3179545

Evaluation of a proposed breast cancer screening regimen.

E G Knox1.   

Abstract

The Forrest working group on breast cancer screening recommended routine mammography for women in the United Kingdom at ages 50, 53, 56, 59, 62, and 65. Benefits were costed at about 3000 pounds for each life year recovered, but there was no estimate of the cost of each life saved, and the consequent reduction in mortality from breast cancer in the general population of the United Kingdom was not estimated. The present study addressed both of these issues using an interactive computer modelling process. Long term savings were calculated at 900 deaths a year in England and Wales--that is, about 8% of the total deaths from breast cancer--and 9% of life years currently lost. The cost of each death saved from breast cancer was estimated at 39,000 pounds.

Entities:  

Mesh:

Year:  1988        PMID: 3179545      PMCID: PMC1834320          DOI: 10.1136/bmj.297.6649.650

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  5 in total

1.  Evidence on screening for breast cancer from a randomized trial.

Authors:  S Shapiro
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

2.  Periodic breast cancer screening in reducing mortality from breast cancer.

Authors:  S Shapiro; P Strax; L Venet
Journal:  JAMA       Date:  1971-03-15       Impact factor: 56.272

3.  Ten- to fourteen-year effect of screening on breast cancer mortality.

Authors:  S Shapiro; W Venet; P Strax; L Venet; R Roeser
Journal:  J Natl Cancer Inst       Date:  1982-08       Impact factor: 13.506

4.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

5.  Ages and frequencies for cervical cancer screening.

Authors:  E G Knox
Journal:  Br J Cancer       Date:  1976-10       Impact factor: 7.640

  5 in total
  4 in total

Review 1.  Calibration methods used in cancer simulation models and suggested reporting guidelines.

Authors:  Natasha K Stout; Amy B Knudsen; Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

2.  Steps towards cost-benefit analysis of regional neurosurgical care.

Authors:  J D Pickard; S Bailey; H Sanderson; M Rees; J S Garfield
Journal:  BMJ       Date:  1990-09-29

3.  Breast cancer screening: its impact on clinical medicine.

Authors:  H J de Koning; G J van Oortmarssen; B M van Ineveld; P J van der Maas
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

4.  A proposal for short-term quality control in breast cancer screening.

Authors:  A L Verbeek; M C Van den Ban; J H Hendriks
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.